Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Beijing Tong Ren Tang Chinese Medicine Co Ltd
Intangible Assets
Beijing Tong Ren Tang Chinese Medicine Co Ltd
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
|
Intangible Assets
HK$66m
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
1%
|
|
|
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
|
Intangible Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
Intangible Assets
HK$3.3B
|
CAGR 3-Years
33%
|
CAGR 5-Years
30%
|
CAGR 10-Years
18%
|
|
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Intangible Assets
¥3.6B
|
CAGR 3-Years
42%
|
CAGR 5-Years
31%
|
CAGR 10-Years
36%
|
|
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Intangible Assets
HK$11.2B
|
CAGR 3-Years
14%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
H
|
HUTCHMED (China) Ltd
HKEX:13
|
Intangible Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beijing Tong Ren Tang Chinese Medicine Co Ltd
Glance View
Beijing Tong Ren Tang Chinese Medicine Co., Ltd. engages in the manufacture, retail and wholesale of Chinese medicine and healthcare products. The company employs 745 full-time employees The company went IPO on 2013-05-07. Along with subsidiaries, it operates its business through three segments. The Hong Kong segment engages in the sale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments through retail outlets as well as wholesale of Chinese medicine products in Hong Kong. The company is also involved in the royalty fee income from overseas entities using the brand of Tong Ren Tang. The Mainland China segment engages in the wholesale of healthcare products in Mainland China and the sole distribution of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd. to customers outside Mainland China. The Overseas segment engages in the retail and wholesale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments in other overseas countries.
See Also
What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's Intangible Assets?
Intangible Assets
66m
HKD
Based on the financial report for Dec 31, 2025, Beijing Tong Ren Tang Chinese Medicine Co Ltd's Intangible Assets amounts to 66m HKD.
What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's Intangible Assets growth rate?
Intangible Assets CAGR 10Y
1%
Over the last year, the Intangible Assets growth was -2%. The average annual Intangible Assets growth rates for Beijing Tong Ren Tang Chinese Medicine Co Ltd have been 3% over the past three years , 4% over the past five years , and 1% over the past ten years .
